Pacific Biosciences of California, Inc. (PACB) vs Sight Sciences, Inc. (SGHT)
- Pacific Biosciences of California, Inc. PACB 1.73 −11.73%
- Sight Sciences, Inc. SGHT 8.28 −5.91%
Pacific Biosciences of California, Inc. and Sight Sciences, Inc. are both Medical Devices companies. Pacific Biosciences of California, Inc. is the larger, with a market value of $609.2M against $484.8M — 1.3× the size. Sight Sciences, Inc. grew revenue faster over the last twelve months: 9.27% against 2.02%. Sight Sciences, Inc. has the higher net margin (−35.7% vs −82.5%) and the lower return on invested capital (−125.2% vs −22.2%). Across the 17 metrics below, Sight Sciences, Inc. leads on 12 and Pacific Biosciences of California, Inc. on 5.
Valuation
Profitability
| Metric | PACB | SGHT | Medical Devices median |
|---|---|---|---|
| Gross margin | 36.38% | 87.96% | 56.01% |
| Operating margin | (83.53%) | (33.43%) | (15.03%) |
| Net margin | (82.49%) | (35.69%) | (20.40%) |
| Free cash flow margin | (50.53%) | (27.98%) | (7.24%) |
| Return on equity | (929.31%) | (48.42%) | (15.32%) |
| Return on assets | (16.66%) | (26.24%) | (19.72%) |
| Return on invested capital | (22.22%) | (125.18%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack